• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Chronic Disease

2 Minute Medicine Rewind November 4-10, 2013

bys25qthea
November 18, 2013
in Chronic Disease, Gastroenterology, Infectious Disease, Nephrology, Public Health, Surgery, Weekly Rewinds
Reading Time: 4 mins read
0
Share on FacebookShare on Twitter

Image: PD

In this section, we will highlight the key high-impact studies, updates, and analyses published in medicine during the past week.

Dolutegravir Plus Abacavir-Lamivudine for the Treatment of HIV-1 Infection

Antiretroviral therapy in the treatment of human immunodeficiency virus (HIV) infection has dramatically improved the survival of HIV-positive patients, but traditional therapy is far from perfect. In this randomized, double-blind, phase 3 trial, 844 previously untreated HIV-positive patients were randomized to treatment with dolutegravir-abacavir-lamivudine or the currently recommended combination therapy (efavirenz-tenofovir disoproxil fumarate-emtricitabine) with a primary outcome of proportion of participants with an undetectable viral load at 48 weeks. Viral suppression was achieved in 88% of the treatment group compared to 81% of those in the control group (p=0.0003). The dolutegravir group also had a shorter median time to viral suppression (28 vs 84 days, p<0.001), greater increase in CD4 T-cell count (difference of 59 cells/mm3, 95% CI 33-84, p<0.001), and fewer reported significant or life-threatening adverse events (10% vs 16%).

Participatory Medicine: A Home Score for Streptococcal Pharyngitis Enabled by Real-Time Biosurveillance: A Cohort Study

Millions of outpatient visits each year for pharyngitis contribute to crowded clinics and patient frustration when no testing or treatment is recommended based on history and physical exam. Researchers analyzed a cohort of 71,776 visits to MinuteClinic urgent care centers in 9 areas of the United States in order to develop a “home score” tool that may be used by patients in deciding whether or not to see a physician at all. The home score is based only on the history (age, fever, absence of cough) and the recent local proportion positive (RLPP) – a biosurveillance marker for local prevalence of the disease in the past 14 days. At a threshold score of <10, the home score had a sensitivity of 99% and a negative predictive value of 0.9. This was comparable to existing models, the Centor and McIsaac scores, which take into account both history and physical exam characteristics (sensitivities of 80% and 75% and negative predictive values of 0.88 and 0.87, respectively). Investigators postulate that if applied nationally, the home score model could result in 230,000 fewer visits annually while missing an additional 8500 cases of GAS compared to a Centor score-based model.

Sofosbuvir and Ledipasvir Fixed-Dose Combination with and without Ribavirin in Treatment-NaĂŻve and Previously Treated Patients with Genotype 1 Hepatitis C Virus Infection (LONESTAR): an Open-Label, Randomised, Phase 2 Trial

RELATED REPORTS

Heliobacter pylori eradication significantly reduces the risk of short-term hospitalization in patients taking low dose aspirin

Dolutegravir associated with improved viral suppression in HIV-positive pregnant patients

Uptake of hepatitis C treatment in people who inject drugs associated with decreased liver disease

Interferon-based therapy has been the standard in treating Hepatitis C virus (HCV) infection, but is not suitable for many patients due to adverse events or contraindications such as psychiatric illness. In this randomized trial, 100 patients with HCV, divided into cohort A (treatment-naïve) and B (previously failed protease inhibitor treatment), were randomized to various interferon-free regimens to study the effect on sustained virological response 12 weeks after treatment (SVR12). Cohort A patients were randomized to receive sofosbuvir + ledipasvir for 8  weeks; sofosbuvir + ledipasvir and ribavirin for 8 weeks; or sofosbuvir + ledipasvir for 12 weeks. Cohort B was randomized to receive sofosbuvir + ledipasvir for 12 weeks or sofosbuvir + ledipasvir and ribavirin for 12 weeks. All participants had rapid reductions in serum HCV RNA, and none had virological breakthrough during treatment. Ninety-seven percent of patients achieved SVR12 and SVR at 24 weeks, irrespective of prior treatment history, disease severity, presence or absence or ribavirin in the treatment regimen, or race. The treatments were not without adverse events, but no patients discontinued treatment because of an adverse event.

Calcium-Channel Blocker – Clarithromycin Drug Interactions and Acute Kidney Injury

Calcium-channel blockers such as amlodipine, nifedipine, and verapamil are metabolized by the cytochrome P450 3A4 enzyme (CYP3A4). Prior case reports and studies have implicated concurrent administration of calcium channel blockers with a CYP3A4 inhibitor such as erythromycin or clarithromycin in hypotension requiring hospitalization. Acute kidney injury (AKI) is a clinically important consequence of hypotension. In this retrospective cohort study, researchers compared the risk of hospitalization for AKI in 190,000 Canadian patients over 65 who were prescribed both a calcium-channel blocker and either clarithromycin, a CYP3A4 inhibitor, or azithromycin. There was a small but statistically significant increase in AKI in patients who received clarithromycin compared to azithromycin (0.44% vs 0.22%, adjusted OR 2.03, 95% CI 1.72-2.41). All-cause mortality was also higher in those who received clarithromycin (adjusted OR 1.74, 95% CI 1.57-1.94). Co-prescribing calcium-channel blockers and CYP3A4 inhibitors such as clarithromycin is common and may result in easily avoidable hospitalizations and costs to the health care system.

Complications of Daytime Elective Laparoscopic Cholecystectomies Performed by Surgeons Who Operated the Night Before

Lack of sleep has been well-established to impair performance in many situations, including in providing medical care. However, prior studies, limited by small sample sizes, found no association between sleep deprivation and attending surgeons’ performance or patient outcomes the day after. In this retrospective cohort study, investigators matched each of 2078 Canadian patients who underwent laparoscopic cholecystectomies by surgeons who had operated between midnight and 7am the night before, to 4 other elective laparoscopic cholecystectomies performed by the same surgeon (n=8312). The primary outcome was conversion to an open cholecystectomy, and researchers found no significant difference between the 2 groups (2.2% vs 1.9% of those who had not operated the night before, adjusted OR 1.18, p=0.33). Similarly, there was no difference in the risk of iatrogenic injuries (OR 0.77, p=0.37) or death (OR not reported, p=0.57). This contradicts safety concerns relating to surgeons operating under sleep deprivation, though it does not take into account possible communication errors or cancelled procedures due to surgeon fatigue.

By Kathleen Li and David Ouyang

© 2013 2minutemedicine.com. All rights reserved. No works may be reproduced without written consent from 2minutemedicine.com. Disclaimer: We present factual information directly from peer reviewed medical journals. No post should be construed as medical advice and is not intended as such by the authors or by 2minutemedicine.com. PLEASE SEE A HEALTHCARE PROVIDER IN YOUR AREA IF YOU SEEK MEDICAL ADVICE OF ANY SORT. Content is produced in accordance with fair use copyrights solely and strictly for the purpose of teaching, news and criticism. No benefit, monetary or otherwise, is realized by any participants or the owner of this domain.

 

Tags: AbacavircholecystectomyClarithromycinDolutegravirhepatitis CLamivudinLedipasvirsofosbuvirstreptococcus
Previous Post

Apgar score for surgery predicts mortality in veterans

Next Post

Increased infections noted with longer duration neonatal PICC placement

RelatedReports

Ultrasound enhances gastrointestinal absorption of drugs at low frequencies
Chronic Disease

Heliobacter pylori eradication significantly reduces the risk of short-term hospitalization in patients taking low dose aspirin

November 16, 2022
Positive physician experience in the Pediatric AIDS Corps
Chronic Disease

Dolutegravir associated with improved viral suppression in HIV-positive pregnant patients

September 5, 2022
Screening insufficient for newborns exposed to hepatitis C virus
Chronic Disease

Uptake of hepatitis C treatment in people who inject drugs associated with decreased liver disease

July 26, 2022
Large spike in drug use-associated infective endocarditis linked with opioid epidemic
Gastroenterology

Accessible hepatitis C care for people who inject drugs provide significantly higher rates of cure compared to conventional care

March 17, 2022
Next Post
Increased infections noted with longer duration neonatal PICC placement

Increased infections noted with longer duration neonatal PICC placement

A quarter of youths with assault injury own a gun

Dramatic rise of gun violence seen in PG-13 movies

Antepartum and intrapartum events both linked to neonatal HIE

Adjuvant misoprostol not associated with improvement in late second-trimester abortions

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • SAR-CoV-2 infection during pregnancy may lead to adverse neurodevelopmental outcomes in male offspring
  • Hyperfractionated radiotherapy reduces complication rates compared to standard fractionation for locally advanced nasopharyngeal carcinoma
  • Lebrikizumab effective in treating moderate-to-severe atopic dermatitis
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

Want more physician-written
medical news?

Join over 10 million yearly readers and numerous companies. For healthcare professionals
and the public.

Subscribe for free today!

Subscription options